FR22C1003I1 - - Google Patents

Info

Publication number
FR22C1003I1
FR22C1003I1 FR22C1003C FR22C1003I1 FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1 FR 22C1003 C FR22C1003 C FR 22C1003C FR 22C1003 I1 FR22C1003 I1 FR 22C1003I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR22C1003I1 publication Critical patent/FR22C1003I1/fr
Application granted granted Critical
Publication of FR22C1003I2 publication Critical patent/FR22C1003I2/fr
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR22C1003C 2010-05-26 2022-01-12 Vaccin contre des infections streptococciques base sur des proteines de recombinaison Active FR22C1003I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34837610P 2010-05-26 2010-05-26
PCT/SE2011/050652 WO2011149419A1 (en) 2010-05-26 2011-05-25 Vaccine against streptococcal infections based on recombinant proteins

Publications (2)

Publication Number Publication Date
FR22C1003I1 true FR22C1003I1 (es) 2022-02-18
FR22C1003I2 FR22C1003I2 (fr) 2023-02-03

Family

ID=45004197

Family Applications (1)

Application Number Title Priority Date Filing Date
FR22C1003C Active FR22C1003I2 (fr) 2010-05-26 2022-01-12 Vaccin contre des infections streptococciques base sur des proteines de recombinaison

Country Status (10)

Country Link
US (2) US9333252B2 (es)
EP (2) EP3135684B1 (es)
CN (1) CN103068838B (es)
AU (1) AU2011258898B2 (es)
CA (1) CA2799136A1 (es)
ES (2) ES2948841T3 (es)
FR (1) FR22C1003I2 (es)
HK (1) HK1183677A1 (es)
NL (1) NL301156I2 (es)
WO (1) WO2011149419A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011059385A1 (en) * 2009-11-13 2011-05-19 Bengt Guss Immunizing composition for reducing streptococcal infections
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
CN104789587B (zh) * 2015-04-10 2018-04-27 新疆农业大学 重组真核表达质粒复合物在制备马腺疫链球菌疫苗的应用
CN115443288A (zh) * 2020-06-18 2022-12-06 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体
CN112011479B (zh) * 2020-08-06 2022-04-22 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 马链球菌马亚种hlj2018d-lx株及其在制备马链球菌马亚种灭活疫苗中的应用
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
WO2024112492A1 (en) * 2022-11-22 2024-05-30 Duke University Compositions comprising antibody cleaving enzymes and method of using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES960488A2 (en) 1996-07-03 1997-11-19 Trinity College Dublin Subunit Vaccine for Streptococcus Equi
FR2750999B1 (fr) 1996-07-10 1998-11-20 Appligene Oncor Adn polymerase thermostable d'archaebacteries du genre pyrococcus sp
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein
ATE471156T1 (de) * 2002-10-11 2010-07-15 Bengt Guss Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
CA2647566C (en) 2006-03-29 2017-01-03 Merial Limited Vaccine against streptococci
GB0624874D0 (en) 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
EP2190984B1 (en) 2007-09-14 2013-09-04 Genovis Ab Methods and kits for purification and detection of glycosylated IgG
EP2227249B1 (en) * 2007-12-13 2018-04-25 Intervacc AB Improved immunizing composition
GB0801326D0 (en) 2008-01-24 2008-03-05 Animal Health Trust Vaccines
AU2010204139A1 (en) 2009-01-12 2011-08-11 Novartis Ag Cna_B domain antigens in vaccines against gram positive bacteria
WO2011059385A1 (en) 2009-11-13 2011-05-19 Bengt Guss Immunizing composition for reducing streptococcal infections

Also Published As

Publication number Publication date
CN103068838B (zh) 2016-03-02
WO2011149419A1 (en) 2011-12-01
US20160082096A1 (en) 2016-03-24
US9333252B2 (en) 2016-05-10
ES2948841T3 (es) 2023-09-20
FR22C1003I2 (fr) 2023-02-03
NL301156I2 (nl) 2022-03-11
EP2590994B1 (en) 2016-11-02
CA2799136A1 (en) 2011-12-01
US20130236469A1 (en) 2013-09-12
EP2590994A4 (en) 2014-04-30
EP2590994A1 (en) 2013-05-15
ES2612520T3 (es) 2017-05-17
EP3135684B1 (en) 2023-06-28
EP3135684A1 (en) 2017-03-01
HK1183677A1 (zh) 2014-01-03
CN103068838A (zh) 2013-04-24
AU2011258898A1 (en) 2012-11-29
US9795664B2 (en) 2017-10-24
EP3135684C0 (en) 2023-06-28
AU2011258898B2 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
BR112013008959A2 (es)
BR112012031500A2 (es)
BR112012029986A2 (es)
BR112012030039A2 (es)
BR112012028408A2 (es)
BR112012026492A2 (es)
BR112012027808A2 (es)
BR112012024897A2 (es)
BR112012025307A2 (es)
BR112012026946A2 (es)
BR112012025482A2 (es)
BR112013006400A2 (es)
BR112012031826A2 (es)
BR112012028186A2 (es)
BR112012025577A2 (es)
BR112012023249A2 (es)
BR112012027015A2 (es)
BR112012025308A2 (es)
BR112012027945A2 (es)
FR22C1003I1 (es)
BR112013010949A2 (es)
BR112012023265A2 (es)
BR112013003284A2 (es)
BR112013002646A2 (es)
BR112012026403A2 (es)